Fulgent Genetics Income After Taxes 2015-2024 | FLGT
Fulgent Genetics income after taxes from 2015 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Fulgent Genetics Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $-175 |
| 2022 | $142 |
| 2021 | $503 |
| 2020 | $219 |
| 2019 | $0 |
| 2018 | $-5 |
| 2017 | $-2 |
| 2016 | $-5 |
| 2015 | $-5 |
| 2014 | $-1 |
| Fulgent Genetics Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-9 |
| 2024-03-31 | $-14 |
| 2023-12-31 | $-134 |
| 2023-09-30 | $-13 |
| 2023-06-30 | $-12 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-24 |
| 2022-09-30 | $1 |
| 2022-06-30 | $11 |
| 2022-03-31 | $154 |
| 2021-12-31 | $104 |
| 2021-09-30 | $122 |
| 2021-06-30 | $76 |
| 2021-03-31 | $201 |
| 2020-12-31 | $168 |
| 2020-09-30 | $49 |
| 2020-06-30 | $4 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-0 |
| 2019-09-30 | $2 |
| 2019-06-30 | $0 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-0 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-4 |
| 2016-03-31 | $-1 |
| 2015-12-31 | |
| 2015-09-30 | $1 |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.589B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.384B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.892B | 183.76 |
| Hims & Hers Health (HIMS) | United States | $5.028B | 130.06 |
| Axonics (AXNX) | United States | $3.600B | 1760.50 |
| IRhythm Technologies (IRTC) | United States | $2.707B | 0.00 |
| Enovis (ENOV) | United States | $2.594B | 17.58 |
| Privia Health (PRVA) | United States | $2.547B | 213.00 |
| Omnicell (OMCL) | United States | $2.306B | 75.97 |
| Azenta (AZTA) | United States | $2.190B | 124.39 |
| 10x Genomics (TXG) | United States | $1.893B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.696B | 0.00 |
| Schrodinger (SDGR) | United States | $1.365B | 0.00 |
| Phreesia (PHR) | United States | $1.228B | 0.00 |
| Standard BioTools (LAB) | United States | $0.800B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.558B | 0.00 |
| Talkspace (TALK) | United States | $0.555B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.500B | 84.80 |
| Health Catalyst (HCAT) | United States | $0.498B | 0.00 |
| Pulmonx (LUNG) | United States | $0.294B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.230B | 0.00 |
| TruBridge (TBRG) | United States | $0.203B | 58.91 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.108B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |